Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 21;12(3):624.
doi: 10.3390/antibiotics12030624.

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database

Nizar Mahmoud Mhaidat  1   2 , Sayer Al-Azzam  1 , Hayaa Abdallah Banat  2 , Jaber Mohammad Jaber  2 , Mohammad Araydah  3 , Osama Y Alshogran  1 , Mamoon A Aldeyab  4
Affiliations

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database

Nizar Mahmoud Mhaidat et al. Antibiotics (Basel). .

Abstract

This study aims to assess the reporting of antimicrobial-related adverse drug events (ADEs) in Jordan between 2003 and 2022. Data regarding the antimicrobial-related ADEs were extracted from the WHO's global database (VigiBase) by the Rational Drug Use and Pharmacovigilance Department at the Jordan Food and Drug Administration (JFDA). A total of 279 Individual Case Safety Reports (ICSRs) were recorded. The number of ICSRs increased from 2019 onwards (219 out of 279 cases). This increase in the reported ADEs was influenced by the actions of the JFDA, including the introduction of electronic reporting forms, updating the national pharmacovigilance guidelines, which encouraged adverse drug reactions reporting, the implementation of the AMR-national action plan, the encouragement to report due to COVID-19 vaccine, and the continuous awareness campaigns and training programs. Skin and subcutaneous tissue disorders (n = 105; 19.48%) were the most reported antimicrobial-related ADEs. The highest number of ADEs was reported for tetracyclines (n = 101; 18.74%) followed by fluoroquinolones (n = 54; 10.02%), third-generation cephalosporines (n = 48; 8.9%), and carbapenems (n = 42; 7.79%). From the top 10 consumed antibiotics, the number of ADEs in patients who consumed Watch group antibiotics (97 ADEs) was higher than those who consumed Access group antibiotics (28 ADEs). The findings highlight the need to monitor and rationalize the use of Watch antibiotics. Enhanced reporting of antimicrobial-related adverse drug reactions is needed to inform antimicrobial stewardship and improve the pharmacovigilance system in Jordan.

Keywords: VigiBase; adverse events; adverse reactions; antimicrobial resistance; antimicrobial stewardship; pharmacovigilance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Trends in the number of Individual Case Safety Reports (ICSRs) in Jordan between 2003 and 2022.
Figure 2
Figure 2
Actions taken for antimicrobial-related ADEs.
See this image and copyright information in PMC

References

    1. Suyagh M., Farah D., Abu Farha R. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc. 2015;23:147–153. doi: 10.1016/j.jsps.2014.07.001. - DOI - PMC - PubMed
    1. Beijer H.J., de Blaey C.J. Hospitalisations caused by adverse drug reactions (ADR): A meta-analysis of observational studies. Pharm. World Sci. PWS. 2002;24:46–54. doi: 10.1023/A:1015570104121. - DOI - PubMed
    1. Leape L.L., Brennan T.A., Laird N., Lawthers A.G., Localio A.R., Barnes B.A., Hebert L., Newhouse J.P., Weiler P.C., Hiatt H. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N. Engl. J. Med. 1991;324:377–384. doi: 10.1056/NEJM199102073240605. - DOI - PubMed
    1. Committee of Experts on Management of Safety and Quality in Health Care (CEMSQHC) Expert Group on Safe Medication Practices: Glossary of Terms Related to Patient and Medication Safety. Council of Europe; Strasbourg, France: 2005.
    1. Leape L.L., Kabcenell A.I., Gandhi T.K., Carver P., Nolan T.W., Berwick D.M. Reducing adverse drug events: Lessons from a breakthrough series collaborative. Jt. Comm. J. Qual. Improv. 2000;26:321–331. doi: 10.1016/S1070-3241(00)26026-4. - DOI - PubMed

LinkOut - more resources